According to a new study from UT Southwestern Medical Center, a dutasteride-tamsulosin combination prescribed for enlarged prostate yielded better results than either of the medicines alone.
The study compared treatments for three groups of study participants with enlarged prostates over four years. Investigation including more than 4,800 men, is one of the first to compare single and combo medication regimens in such a large group.
Researchers found the combination therapy to be superior at reducing risk of BPH progression as the two medications joined forces in terms of symptom control. On the strengths of both dutasteride and tamsulosin, participants reported fewer symptoms, and researchers observed a 25 percent reduction in prostate volume
The study findings are published in a recent issue of the journal European Urology.
